The Role of IL-1R1 in cell transitions in Aortic Aneurysm Pathogenesis
The Role of IL-1R1 in cell transitions in Aortic Aneurysm Pathogenesis
批准号:
9042424
负责人:
Gorav Ailawadi
金额:
$48.66万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-04-01 至 2020-02-29
关键词:
Abdominal Aortic AneurysmAffectAneurysmAngiotensin IIAntibodiesAortic AneurysmApoptosisAttenuatedB-LymphocytesBloodBlood CirculationCCL2 geneCaliberCardiovascular DiseasesCause of DeathCell Culture SystemCell LineageCellsChronicClinicalClinical TrialsCollagenCoupledDataDevelopmentDiseaseElastasesElastinElderlyEpigenetic ProcessExhibitsFlow CytometryGelatinase AGelatinase BGenesGeneticGoalsHarvestHealthHistologyHumanIL1R1 geneImmuneImmunohistochemistryIncidenceInfiltrationInflammationInflammatoryInterleukin-1Interleukin-1 ReceptorsInterleukin-1 betaInterventionKnock-outKnockout MiceLabelLaboratoriesLesionLeukocytesMeasuresMedicalMethodsMicroscopicModelingMusMuscleMyelogenousMyeloid CellsMyocardial InfarctionMyosin Heavy ChainsNeutrophil InfiltrationPathogenesisPathologyPathway interactionsPatientsPerfusionPhenotypePlasminogen Activator Inhibitor 1PlayPrevalencePreventionProductionPublicationsPublishingPumpRANTESRecombinant Interleukin-1ResolutionRoleRuptureSamplingSecondary toSerine ProteaseSignal PathwaySignal TransductionSmooth MuscleSmooth Muscle MyocytesStagingT-LymphocyteTNF geneTamoxifenTestingTissuesTranslatingWestern Blottinganakinraattenuationbasecell typeclinically relevantcytokineinhibitor/antagonistmacrophagemalemouse modelneutrophilnovelnovel markerpreventprotective effectreceptortreatment strategy
中文摘要
描述(申请人提供):假设:我们之前使用弹性酶灌注腹主动脉瘤(AAA)模型的研究表明,IL-1R1KO小鼠的动脉瘤发生率和动脉瘤形成的大小都有所降低。我们最近还表明,在预防和治疗研究中,使用IL-1途径抑制剂Anakinra对AAA小鼠模型的动脉瘤形成具有显著的保护作用。在目前的方案中,我们将使用新的严格的腹主动脉瘤(AAA)形成的小鼠模型来研究IL-1信号在平滑肌和巨噬细胞表型转变中的作用,并研究IL-1R1信号在AAA形成中的机制,作为一种有选择地确定预防AAA形成的治疗策略的方法。方法:在条件性IL-1受体1KO小鼠中,我们将使用弹性蛋白酶灌流和血管紧张素II小鼠模型结合严格的血管和巨噬细胞系谱追踪分析。Anakinra治疗将通过渗透压泵给予,以确定Anakinra治疗在动脉瘤形成过程中对平滑肌细胞和巨噬细胞转变的作用。分别于第3、7、14、28天测量主动脉直径。用酶谱法检测促炎症细胞因子(IL-1、β、α、MCP-1、IL-6、RANTES)的活性,免疫印迹法检测丝氨酸蛋白酶(uPA、tPA、PAI-1),组织学检测弹性蛋白、胶原的降解情况,流式细胞仪检测免疫细胞(巨噬细胞、T细胞、中性粒细胞、B细胞)的表达。结果:初步数据显示,在AAA形成中注入弹性酶14天后,IL-1R1KO小鼠的动脉瘤形成显著减少。在TAA形成前3天通过渗透泵给予Anakinra的野生型雄性小鼠也显示出主动脉内径减小。与野生型雄性小鼠相比,IL1β和IL1R1KO雄性小鼠的主动脉内径缩小,细胞因子(肿瘤坏死因子α、单核细胞趋化蛋白-1、IL-6和IL-27)的产生减少,基质金属蛋白酶-9的表达减少,巨噬细胞和中性粒细胞的浸润减少。最后,通过定量聚合酶链式反应和免疫组织化学,IL-1R1在人AAA样本中比非动脉瘤对照中增加。结论:抑制IL-1通路可减轻弹力酶诱导的AAA小鼠模型的动脉瘤形成和炎症反应。我们建议通过对血管和巨噬细胞的新的谱系追踪分析来描述IL-1信号在AAA形成中的机制,并研究IL-1信号在动脉瘤形成的病理中的作用,以开发动脉瘤治疗的总体目标。
英文摘要
DESCRIPTION (provided by applicant): Hypothesis: Our previous studies using elastase-perfusion models of abdominal aortic aneurysms (AAA) have shown that IL-1R1 KO mice have a decreased incidence and size of aneurysm formation. We have also recently shown that treatment with the IL-1 pathway inhibitor, anakinra, in both prevention and treatment studies results in significant protection from aneurysm formation in a mouse model of AAA. In the current proposal, we will investigate the role of IL-1 signaling in smooth muscle and macrophage phenotypic transitions using novel rigorous lineage tracing mouse models of abdominal aortic aneurysm (AAA) formation and to examine the mechanism of IL-1R1 signaling in AAA formation as a method to selectively determine treatment strategies to protect against AAA formation. Methods: We will use a elastase perfusion and Angiotensin II murine models of AAA coupled with rigorous smooth muscle and macrophage lineage tracing analysis in conditional IL-1 receptor 1 KO mice. Anakinra treatment will be administered via osmotic pump to determine the role of Anakinra treatment on smooth muscle cell and macrophage transitions during aneurysm formation. Aortic diameter will be measured on day 3, 7, 14, and 28. Aortic tissue will be harvested to analyze pro-inflammatory cytokine (IL-1β, TNF-α, MCP-1, IL-6, and RANTES), MMP-2 and MMP-9 activity by zymography, serine proteases (uPA, tPA and PAI-1) by western blots, elastin and collagen degradation as well as aortic smooth muscle expression by histology, and immune cell (macrophages, T cells, neutrophils, B cells) infiltration by flow cytometry. Results: Preliminary data found significant attenuation in aneurysm formation in IL-1R1 KO mice 14 days following elastase perfusion in AAA formation. Wild-type male mice administered anakinra via osmotic pump 3 days before TAA formation also exhibited decreased aortic diameter. AAA formation in IL1β and IL1R1 KO male mice display a decreased aortic diameter, decreased cytokine production (TNFα, MCP-1, IL-6 and IL-27), decreased MMP-9 expression and decreased macrophage and neutrophil infiltration compared to wild-type male mice. Finally, IL-1R1 is increased in human AAA samples versus non-aneurysmal controls via qPCR and immunohistochemistry. Conclusions: IL-1 pathway inhibition can attenuate aneurysm formation and inflammation in the topical elastase murine model of AAA. We propose to delineate the mechanism of IL-1 signaling in AAA formation using novel lineage tracing analysis in smooth muscle cell and macrophages and to examine the role of IL-1 signaling in the pathology of aneurysm formation with the overall goal to develop aneurysm treatment.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Surgeon Scientist Training in Cardiac Diseases
-
批准号:10553973
-
项目类别:
-
资助金额:$19.94万
-
财政年份:2023
-
负责人:Gorav Ailawadi
-
依托单位:
The Effects of KLF4 in experimental aortic aneurysm formation
-
批准号:8586539
-
项目类别:
-
资助金额:$13.12万
-
财政年份:2010
-
负责人:Gorav Ailawadi
-
依托单位:
The Effects of KLF4 in experimental aortic aneurysm formation
-
批准号:8024545
-
项目类别:
-
资助金额:$13.12万
-
财政年份:2010
-
负责人:Gorav Ailawadi
-
依托单位:
The Effects of KLF4 in experimental aortic aneurysm formation
-
批准号:7772440
-
项目类别:
-
资助金额:$13.12万
-
财政年份:2010
-
负责人:Gorav Ailawadi
-
依托单位:
The Effects of KLF4 in experimental aortic aneurysm formation
-
批准号:8403747
-
项目类别:
-
资助金额:$13.12万
-
财政年份:2010
-
负责人:Gorav Ailawadi
-
依托单位:
The Effects of KLF4 in experimental aortic aneurysm formation
-
批准号:8204609
-
项目类别:
-
资助金额:$13.12万
-
财政年份:2010
-
负责人:Gorav Ailawadi
-
依托单位:
Cardiothoracic Surgical Trials Network Linked Clinical Research Centers for Virginia and West Virginia
-
批准号:9755143
-
项目类别:
-
资助金额:$61.9万
-
财政年份:2007
-
负责人:Gorav Ailawadi
-
依托单位:
海外基金